Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis.
Du H, Li X, Su N, Li L, Hao X, Gao H, Kwong JS, Vandvik PO, Yang X, Nemeth I, Mordi IR, Li Q, Zhang L, Rao L, Lang CC, Li J, Tian H, Li S.
Du H, et al. Among authors: li s, li j, li x, li l, li q.
Heart. 2019 Aug;105(15):1149-1159. doi: 10.1136/heartjnl-2019-314763. Epub 2019 Mar 6.
Heart. 2019.
PMID: 30842207